Contact tracing in pulmonary versus non-pulmonary tuberculosis- the impact of the 2016 NICE guidelines?

C. Craig (Manchester, United Kingdom)

Source: International Congress 2017 – Migrants and screening
Session: Migrants and screening
Session type: Thematic Poster
Number: 2687
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Craig (Manchester, United Kingdom). Contact tracing in pulmonary versus non-pulmonary tuberculosis- the impact of the 2016 NICE guidelines?. 2687

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What is new in the 2019 ESC/ERS guidelines for the management of pulmonary embolism?
Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines
Year: 2019


Compliance with BTS and NICE guidelines in assessment of possible pulmonary embolism
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021


The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress
Source: Eur Respir J 2015; 46: 879-882
Year: 2015


Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020
Year: 2020



Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Source: Guideline 2020
Year: 2020

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Source: Guideline 2015
Year: 2021


Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists?
Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases
Year: 2007


Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases
Source: Eur Respir J , 49 (2) 1601855; DOI: 10.1183/13993003.01855-2016
Year: 2017


Management of pulmonary embolism: recent evidence and the new European guidelines
Source: Eur Respir J 2014; 44: 1385-1390
Year: 2014


Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
Source: Eur Respir Rev 2009; 18: 272-290
Year: 2009



Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre
Source: Guideline 2009
Year: 2009

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Eur Respir J, 54 (3) 1901647; 10.1183/13993003.01647-2019
Year: 2019



2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Guideline 2019
Year: 2019

Economic impact of pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 472s
Year: 2004

Does NICE COPD audit tools affect management of COPD?
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013


Radiologic profile of treated pulmonary tuberculosis patients and their correlation with modified medical research council scale and spirometry
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
Source: Eur Respir Rev, 31 (163) 210165; 10.1183/16000617.0165-2021
Year: 2022